Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities
Net income	$ 217,695	$ 140,496
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	804,658	249,465
Interest from amortization of debt costs	3,860
Stock based compensation	92,241	119,940
Bad debt expense	(6,142)
Change in fair value of warrant liability	(48,380)	(43,500)
Change in fair value of seller's note	28,990
Deferred rent	(19,985)	(32,346)
Inventory write-offs to reserves		41,143
Changes in operating assets and liabilities:
Trade accounts receivables	737,036	232,466
Other receivables	(22,417)	88,073
Inventories	(432,216)	(269,111)
Prepaid expenses and other assets	(19,786)	29,680
Accounts payable and accrued liabilities	319,537	365,587
Net cash provided by operating activities	1,655,090	921,893
Cash flows from investing activities
Purchase of property and equipment	(1,411,278)	(387,259)
Net cash used in investing activities	(1,411,278)	(387,259)
Cash flows from financing activities
Proceeds from sale of common stock from employee stock purchase plan	19,080	9,598
Proceeds from exercise of warrants, net of costs	30,250	70,957
Net payments on loan payable	(278,249)
Payments on capital lease obligations	(53,100)	(35,300)
Net cash provided by (used in) financing activities	(282,019)	45,255
Effect of exchange rate on cash and cash equivalents	11,343	95,859
Change in cash and cash equivalents	(26,864)	675,748
Cash and cash equivalents, beginning of period	8,085,015	2,908,024
Cash and cash equivalents, end of period	8,058,151	3,583,772
Supplemental disclosure of cash flow information:
Interest paid in cash	85,910	6,941
Income taxes paid	336,014	116,043
Supplemental disclosure of non-cash investing & financing activities:
Reclassification of warrant liability upon exercise	$ 34,500	$ 52,424